Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Esophageal Disorders
•
Stomach Disorders
Is there evidence that certain PPIs provide superior clinical efficacy compared to others in real-world practice?
Related Questions
In a patient with Zieve's Syndrome and alcohol related cirrhosis which antibiotic regimen is safe to treat H. pylori?
How would you approach endoscopic diagnosis and treatment of an area of visible nodularity concerning for cancer within long segment Barrett’s esophagus?
In patients with EGJOO on esophageal manometry, how do you approach subsequent testing for further evaluation?
How do you approach a referral for findings of intestinal metaplasia on a biopsy of an irregular z-line?
How will the findings from the recent BOSS study affect your management of Barrett's esophagus without dysplasia?
How do you approach H. pylori management in terms of evaluating or testing family members of patients who test positive?
What Barrett's Esophagus screening protocol do you follow for patients with scleroderma given the increased risk of reflux and esophageal stasis?
How do you diagnose and manage suspected opioid-induced esophageal dysfunction?
What new or emerging therapies for autoimmune gastritis are available beyond iron and vitamin B12 replacement?
How do you approach surveillance and repeat biopsies in a patient with a diagnosis of intestinal metaplasia (aka Barrett's esophagus) on pathology who appears to have a regular Z-line or <1 cm of salmon mucosa?